Proteins of the ETS family with transcriptional repressor activity
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
ETS proteins form one of the largest families of signal-dependent transcriptional regulators, mediating cellular proliferation, differentiation and tumorigenesis. Most of the known ETS proteins have been shown to activate transcription. However, four ETS proteins (YAN, ERF, NET and TEL) can act as transcriptional repressors. In three cases (ERF, NET and TEL) distinct repression domains have been identified and there are indications that NET and TEL may mediate transcription via Histone Deacetylase recruitment. All four proteins appear to be regulated by MAPKs, though for YAN and ERF this regulation seems to be restricted to ERKs. YAN, ERF and TEL have been implicated in cellular proliferation although there are indications suggesting a possible involvement of YAN and TEL in differentiation as well. Other ETS-domain proteins have been shown to repress transcription in a context specific manner, and there are suggestions that the ETS DNA-binding domain may act as a transcriptional repressor. Transcriptional repression by ETS domain proteins adds an other level in the orchestrated regulation by this diverse family of transcription factors that often recognize similar if not identical binding sites on DNA and are believed to regulate critical genes in a variety of biological processes. Definitive assessment of the importance of this novel regulatory level will require the identification of ETS proteins target genes and the further analysis of transcriptional control and biological function of these proteins in defined pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The SPI1 protein does not contain any transcriptional repression domain (48) but interacts with several cofactors that may mediate its repressive activity.”
From HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia (2022) · cites this paper as [48]
In the citing paper
“It also has the oligomerization domain (also called the pointed [PNT] domain, B domain, or HLH domain) in the N terminus that is conserved in several Ets members, but not in PU.1 (33, 39).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [33]
In the citing paper
“TEL represses transcription through the Ets site, and repression may be attributed to the recruitment of mSin3A, corepressor N-CoR, and histone deacetylase HDAC3 (7, 14, 29, 33, 55).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [33]
Citations
Cites
Methylation-Induced Repression— Belts, Braces, and Chromatin
Bird, A. P., & Wolffe, A. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81532-9 · Cited by 1,827
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759 · cited 1×
“Most members of the RTK signaling pathways are highly conserved through evolution from the receptors to the MAPKs (for a comprehensive review see Lewis et al., 1998).”
BackgroundInduction of Ectopic Eyes by Targeted Expression of the eyeless Gene in Drosophila
Halder, G., Callaerts, P., & Gehring, W. J. (1995) · Science · doi:10.1126/science.7892602 · Cited by 1,573 · cited 1×
“A role of yan in proliferation rather than di erentiation is further supported by the identi®cation of a master key gene in eye development (Halder et al., 1995a,b) although regulation of this gene by yan cannot be excluded (Rebay et al., 2000).”
BackgroundThe SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
Marais, R., Wynne, J., & Treisman, R. (1993) · Cell · doi:10.1016/0092-8674(93)90237-k · Cited by 1,275 · cited 1×
“…their subcellular compartmentalization (Le Gallic et al., 1999; Ducret et al., 1999), their DNAbinding activity (Rabault and Ghysdael, 1994; Martin et al., 1996; Cowley and Graves, 2000) or their transactivation potential (Marais et al., 1993; O'Hagen et al., 1996; McCarthy et al., 1997).”
BackgroundA complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W.-M., Brard, G., Ngo, S. D., Davie, J. R., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,214 · cited 1×
“However, there is a report indicating that ERF mediated repression may not involve the Sin3/NcoR system (Heinzel et al., 1997).”
BackgroundGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842 · cited 1×
“…1990) and have been shown to mediate cellular proliferation, di erentiation and tumorigenesis (for reviews see Watson et al., 1990; Seth et al., 1992; Macleod et al., 1992; Wasylyk et al., 1993; Ghysdael and Boureux, 1997; Dittmer and Nordheim, 1998; Papas et al., 1997; Ghosh and Kolodkin, 1998).”
BackgroundA TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Self-citationFusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704 · cited 12×
“AML1, together with an unrelated CBFb subunit, binds speci®c DNA sequences through its 128 aminoacids runt domain and functions either as transcriptional activator or repressor, depending on the promoter/enhancer tested.”
MethodInfluentialTernary complex factors: growth factor regulated transcriptional activators
Treisman, R. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90097-3 · Cited by 676 · cited 1×
“…G Mavrothalassitis of many promoters/enhancers by ETS proteins often critically depend upon their interaction with unrelated transcription factors on composite DNA elements (Dalton and Treisman, 1992; Janknecht et al., 1993; Treisman, 1994; Giese et al., 1995; Wolberger, 1998; Goetze et al., 2000).”
Background
Research works printed but not linked: 4
- Ito Y and Bae S. . 1997 The RuntDomain Transcriptio Factor, PEBP2/CBF, and its involvement in human leukemia. In: Oncogenes as Transcriptional Regulators, M Yaniv and J Ghysdael, (eds) Vol. 2. Birkhauser Verlag: Basel, Switzerland pp. 107–132.
- Lopez M, Oettgen P, Akbarali Y, Dendorfer U and Libermann TA. . 1994 Mol. Cell. Biol. 14: 3292–3309. · doi:10.1128/mcb.14.5.3292-3309.1994 · Paper page
- Poirel H, Lopez RG, Lacronique V, Della Valle V, Mauchauffe M, Berger R, Ghysdael J and Bernard O. . 2000 Oncogene in press.
- Spyropoulos ? . 2000 Oncogene, (this edition).
Cited by
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation
Plotnikov, A., Zehorai, E., Procaccia, S., & Seger, R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.012 · Cited by 986
“One of the main transcription repressors that are regulated by ERK1/2 is the Ets2 repressor factor (Erf1), which suppresses transcription in many resting cells [100].”
BackgroundChang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568
“In translocations observed in some cancer types, the ETS DNA-binding domain (DBD) is lost, and the ETS partner contributes a regulatory domain to another class of DBD (e.g. ETV6-RUNX1; Golub et al, 1995; Mavrothalassitis and Ghysdael, 2000).”
The ERK Cascade: Distinct Functions within Various Subcellular Organelles
Wortzel, I., & Seger, R. (2011) · Genes & Cancer · doi:10.1177/1947601911407328 · Cited by 563
Role of RUNX1 in hematological malignancies
Sood, R., Kamikubo, Y., & Liu, P. (2017) · Blood · doi:10.1182/blood-2016-10-687830 · Cited by 494
“It is likely that oligomerization of ETV6 allows for stable formation of repressor–corepressor complexes.(94) Studies of identical twins with concordant ALL provide unequivocal evidence that ETV6-RUNX1 arises prenatally.”
BackgroundBarolo, S., & Posakony, J. W. (2002) · Genes & Development · doi:10.1101/gad.976502 · Cited by 468
“The vertebrate Ets repressor protein ERF, which is excluded from the nucleus in response to Ras/MAPK signaling , may serve a function analogous to that of Yan (Mavrothalassitis and Ghysdael 2000).”
BackgroundInfluentialETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
“Similar retroviral bone marrow transduction and transplantation studies demonstrated that TEL–ABL has leukaemogenic properties in vivo [58].”
BackgroundEts ternary complex transcription factors
Buchwalter, G., Gross, C., & Wasylyk, B. (2004) · Gene · doi:10.1016/j.gene.2003.09.028 · Cited by 336
Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface
Hunter, M. V., Moncada, R., Weiss, J. M., Yanai, I., & White, R. M. (2021) · Nature Communications · doi:10.1038/s41467-021-26614-z · Cited by 285
Ghisletti, S., Huang, W., Jepsen, K., Benner, C., Hardiman, G., Rosenfeld, M. G., & Glass, C. K. (2009) · Genes & Development · doi:10.1101/gad.1773109 · Cited by 248
“GENES & DEVELOPMENT 685 repressors (Mavrothalassitis and Ghysdael 2000).”
SubCellBarCode: Proteome-wide Mapping of Protein Localization and Relocalization
Orre, L. M., Vesterlund, M., Pan, Y., Arslan, T., Zhu, Y., Fernandez Woodbridge, A., Frings, O., Fredlund, E., & Lehtiö, J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.035 · Cited by 199
Mutant p53 cooperates with ETS2 to promote etoposide resistance
Do, P. M., Varanasi, L., Fan, S., Li, C., Kubacka, I., Newman, V., Chauhan, K., Daniels, S. R., Boccetta, M., Garrett, M. R., et al. (2012) · Genes & Development · doi:10.1101/gad.181685.111 · Cited by 196
“The ETS gene family is composed of 28 members, and their defining feature is the presence of the ETS domain, which is involved in DNA binding (Mavrothalassitis and Ghysdael 2000; Hollenhorst et al. 2011).”
BackgroundETV6 fusion genes in hematological malignancies: A review
De Braekeleer, E., Douet-Guilbert, N., Morel, F., Le Bris, M.-J., Basinko, A., & De Braekeleer, M. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.04.010 · Cited by 194
Tootle, T. L., & Rebay, I. (2005) · BioEssays · doi:10.1002/bies.20198 · Cited by 175
“The majority function as transcriptional activators, while some possess repressive activities, and others, in a context-dependent manner, act as both activators and repressors.((4,6,14)) One-third of ETS transcription factors also contain a conserved amino-terminal domain called the Pointed Domain (PD).”
BackgroundZelent, A., Greaves, M., & Enver, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207672 · Cited by 174
“The wild-type TEL, on the other hand, can self-associate via its PD domain and is thought to form dimers or oligomers (Jousset et al., 1997; Lopez et al., 1999; Mavrothalassitis and Ghysdael, 2000).”
BackgroundETS transcription factors and regulation of immunity
Gallant, S., & Gilkeson, G. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0017-z · Cited by 163
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
Kar, A., & Gutierrez‐Hartmann, A. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838202 · Cited by 169
“Other examples, where post-translational modifications have resulted in transcriptional activation affecting transformation include that of ELK-1 and ELF-1.”
BackgroundInfluentialEts2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc
Xu, D., Dwyer, J., Li, H., Duan, W., & Liu, J.-P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800790200 · Cited by 142
When Ets transcription factors meet their partners
Verger, A., & Duterque‐Coquillaud, M. (2002) · BioEssays · doi:10.1002/bies.10068 · Cited by 134
Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis
Dejana, E., Taddei, A., & RANDI, A. M. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.003 · Cited by 154
An Induced Ets Repressor Complex Regulates Growth Arrest during Terminal Macrophage Differentiation
Klappacher, G., Lunyak, V. V., Sykes, D. B., Sawka‐Verhelle, D., Sage, J., Brard, G., Ngo, S. D., Gangadharan, D., Jacks, T., Kamps, M. P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00714-6 · Cited by 125
ABL1 fusion genes in hematological malignancies: a review
Braekeleer, E. D., Douet‐Guilbert, N., Rowe, D. W., Bown, N. P., Morel, F., Berthou, C., Férec, C., & Braekeleer, M. D. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01586.x · Cited by 119
Understanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes
Findlay, V. J., LaRue, A. C., Turner, D. P., Watson, P. M., & Watson, D. K. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00001-0 · Cited by 125
Morrow, M., Horton, S. J., Kioussis, D., Brady, H. J. M., & Williams, O. (2004) · Blood · doi:10.1182/blood-2003-10-3695 · Cited by 116
Molecular mechanisms of megakaryopoiesis
Szalai, G., LaRue, A. C., & Watson, D. K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6190-8 · Cited by 125
Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis
Jackers, P., Szalai, G., Moussa, O., & Watson, D. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407489200 · Cited by 91
Kramer, G., Steiner, G., Gröbl, M., Hrachowitz, K., Reithmayr, F., Paucz, L., Newman, M., Madersbacher, S., Gruber, D., Susani, M., et al. (2003) · The Prostate · doi:10.1002/pros.10314 · Cited by 81
“Of the Ets-related proteins TEL [12], the only ETS member with transcriptional repressor activity which is associated with human malignancy, was upregulated <2 times.”
ERF Nuclear Shuttling, a Continuous Monitor of Erk Activity That Links It to Cell Cycle Progression
Le Gallic, L., Virgilio, L., Cohen, P., Biteau, B., & Mavrothalassitis, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1206-1218.2004 · Cited by 73
Self-citationSp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity
Wasylyk, C., Schlumberger, S. E., Criqui-Filipe, P., & Wasylyk, B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2687-2702.2002 · Cited by 81
Zadora, P. K., Chumduri, C., Imami, K., Berger, H., Mi, Y., Selbach, M., Meyer, T. F., & Gurumurthy, R. K. (2018) · Cell Reports · doi:10.1016/j.celrep.2019.01.006 · Cited by 77
“ERF, another member of the ETS family, is a potent, ubiquitously expressed transcriptional repressor that recognizes promoters with the EBS motif and regulates genes involved in proliferation and Ras-induced tumorigenicity (Allegra et al., 2012; Mavrothalassitis and Ghysdael, 2000; Sgouras et al., 1995).”
The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome.
Seki, Y., Suico, M. A., Uto, A., Hisatsune, A., Shuto, T., Isohama, Y., & Kai, H. (2002) · PubMed · Cited by 72
Kuwata, T., Gongora, C., Kanno, Y., Sakaguchi, K., Tamura, T., Kanno, T., Basrur, V., Martinez, R., Appella, E., Golub, T., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7439-7448.2002 · Cited by 69
“TEL represses transcription through the Ets site, and repression may be attributed to the recruitment of mSin3A, corepressor N-CoR, and histone deacetylase HDAC3 (7, 14, 29, 33, 55).”
BackgroundBuchwalter, G., Hickey, M. M., Cromer, A., Selfors, L. M., Gunawardane, R. N., Frishman, J., Jeselsohn, R. M., Lim, E., Chi, D., Fu, X., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.026 · Cited by 72
“Several other ETS factors also display transcriptional-repressive activities, including Net, Yan, ERF, and Tel (Mavrothalassitis and Ghysdael, 2000).”
Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons
Lee, P. R., Cohen, J. E., Iacobas, D. A., Iacobas, S., & Fields, R. D. (2017) · Scientific Reports · doi:10.1038/srep43765 · Cited by 50
RETRACTED: Highly specific urine-based marker of bladder cancer
Le, T.-S. V., Miller, R., Barder, T. J., Babjuk, M. M., Potter, D. M., & Getzenberg, R. H. (2005) · Urology · doi:10.1016/j.urology.2005.07.010 · Cited by 63
RetractedTranscriptional regulation of miR-196b by ETS2 in gastric cancer cells
Liao, Y.-L., Hu, L., Tsai, K., Wu, C.-W., Chan, W., Li, S., Lai, C.-H., Ho, M., Fang, W., Huang, K., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs023 · Cited by 69
Functional Characterization of the Bladder Cancer Marker, BLCA-4
Le, T.-S. V., Myers, J., Konety, B. R., Barder, T. J., & Getzenberg, R. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0455-03 · Cited by 63
RetractedEts family members induce lymphangiogenesis through physical and functional interaction with Prox1
Yoshimatsu, Y., Yamazaki, T., Mihira, H., Itoh, T., Suehiro, J., Yuki, K., Harada, K., Morikawa, M., Iwata, C., Minami, T., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.083998 · Cited by 68
“Notably, two repressors of the Ets family have been shown to bind to Prox1, whereas most Ets family members activate transcription (Mavrothalassitis and Ghysdael, 2000).”
BackgroundTranscriptional regulation of phosphatidylcholine biosynthesis
Sugimoto, H., Banchio, C., & Vance, D. E. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.01.002 · Cited by 66
Liu, X., Wang, L., Zhang, S., Lin, J., Zhang, S., Feitelson, M. A., Gao, H., & Zhu, M.-H. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn111 · Cited by 57
Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein
Spahn, L., Siligan, C., Bachmaier, R., Schmid, J. A., Aryee, D. N. T., & Kovar, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206810 · Cited by 61
“…the selfassociation properties of germline FLI1 which has previously been demonstrated to interact with other ets proteins, including ERG and TEL, via its N-terminal pointed domain (Mavrothalassitis and Ghysdael, 2000), and of the isolated EWS NTDEWS present in EWS and EWS-ets fusion proteins.”
BackgroundBain, M., Mendelson, M., & Sinclair, J. H. (2003) · Journal of General Virology · doi:10.1099/vir.0.18633-0 · Cited by 68
“To date, most mammalian ets family members function as transcriptional activators (for reviews see Dittmer & Nordheim, 1998, Mavrothalassitis & Ghysdael, 2000), which is not in keeping with the proposed role of MBF1 in the repression of the MIEP.”
BackgroundHayashi, T., Xu, C., & Carthew, R. W. (2008) · Development · doi:10.1242/dev.006189 · Cited by 51
“D E V E LO P M E N T 2794 Frasch, 2001; Mettler et al., 2006; Zelhof et al., 1995).”
Identification of casein kinase Iα interacting protein partners
Dubois, T., Howell, S. A., Zemlickova, E., & Aitken, A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02614-5 · Cited by 45
The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis
Cardone, M., Kandilci, A., Carella, C., Nilsson, J. A., Brennan, J. A., Ekmekçi, S. S., Özbek, U., Boyd, K. L., Cleveland, J. L., & Grosveld, G. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2395-2405.2005 · Cited by 52
“TEL1 is currently the only member of this subfamily of ETS transcriptional repressors associated with human malignancy (23).”
BackgroundTranscriptional Regulation of Pro-apoptotic Protein Kinase Cδ
Jin, H., Kanthasamy, A., Anantharam, V., Rana, A., & Kanthasamy, A. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203687 · Cited by 47
Li, Y., Wang, Y., Zhang, C., Yuan, W., Wang, J., Zhu, C., Chen, L., Huang, W., Zeng, W., Wu, X., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.183 · Cited by 42
FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain
Maurer, P., T'Sas, F., Coutte, L., Callens, N., Brenner, C., Lint, C. M. V., de Launoit, Y., & Baert, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206572 · Cited by 43
“Of the approximately 30 Ets proteins currently characterized in mammals, only Net (Net, Net-b, Netc), Erf, and Tel (Tel and Tel-2) have been identified as transcriptional repressors (Mavrothalassitis and Ghysdael, 2000).”
BackgroundTFAP2 paralogs facilitate chromatin access for MITF at pigmentation and cell proliferation genes
Kenny, C., Dilshat, R., Seberg, H., Otterloo, E. V., Bonde, G., Helverson, A., Franke, C. M., Steingrímsson, E., & Cornell, R. A. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010207 · Cited by 43
“The binding site for TFAP2 was strongly enriched for in these enhancers, as were those for ETS1 and CTCF (Fig 3O), both transcriptional repressors [75,76].”
BackgroundERF and ETV3L are retinoic acid-inducible repressors required for primary neurogenesis
Janesick, A., Abbey, R. J., Chung, C. M., Liu, S., Taketani, M., & Blumberg, B. (2013) · Development · doi:10.1242/dev.093716 · Cited by 45
“…function as transcriptional activators or repressors that interact with other factors to facilitate combinatorial, context-specific regulation of gene expression (reviewed by Hollenhorst et al., 2011; Li et al., 2000; Mavrothalassitis and Ghysdael, 2000; Oikawa and Yamada, 2003; Sharrocks, 2001).”
BackgroundLongevity is determined by ETS transcription factors in multiple tissues and diverse species
Dobson, A. J., Boulton-McDonald, R., Houchou, L., Svermova, T., Ren, Z., Subrini, J., Vazquez-Prada, M., Hoti, M., Rodríguez‐López, M., Ibrahim, R., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008212 · Cited by 40
“Aop and its human orthologue Tel are thought to repress transcription by competing with activators for binding sites[21,23], recruiting co-repressors[22,24,25], and forming homo-oligomers that limit activator access to euchromatin[26–30].”
BackgroundAutoinhibition of ETV6 (TEL) DNA Binding: Appended Helices Sterically Block the ETS Domain
Coyne, H. J., De, S., Okon, M., Green, S. M., Bhachech, N., Graves, B. J., & McIntosh, L. P. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.05.010 · Cited by 40
The Role of Mitogen-Activated ERK-Kinase Inhibitors in Lung Cancer Therapy
Adjei, A. A. (2005) · Clinical Lung Cancer · doi:10.3816/clc.2005.n.040 · Cited by 37
Ets2 transcription factor, telomerase activity and breast cancer
Dwyer, J., & Liu, J. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05236.x · Cited by 37
Tiensuu, T., Larsen, M. K., Vernersson, E., & Tuck, S. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.08.007 · Cited by 32
Klein, R. H., Hu, W. K., Kashgari, G. Y., Lin, Z., Nguyen, T. T. L., Doan, M., & D, B. A. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.793117 · Cited by 36
“In agreement with this mechanism, a number of Ets family members, including EHF, have been shown previously to be able to repress gene expression (18, 31, 32).”
BackgroundRouget, R., Vigneault, F., CODIO, C., Rochette, C., Paradis, I., Drouin, R., & Simard, L. R. (2005) · Biochemical Journal · doi:10.1042/bj20041024 · Cited by 34
Liu, B., Zhang, J., Meng, X. Z., Xie, S. M., Liu, F., Chen, H., Yao, D., Li, M., Guo, M., Shen, H., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02641-6 · Cited by 32
“ETS transcription factors can act as transcriptional activators and/or repressors depending on gene and context [29].”
BackgroundZhang, J., Graham, T. G. W., Vivekanand, P., Cote, L., Cetera, M., & Rebay, I. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01225-09 · Cited by 29
“Yan is evolutionarily conserved (8, 14, 17), and its mammalian homologue Tel is a transcriptional repressor frequently mutated in human leukemias (2).”
BackgroundMiley, G. R., Fantz, D., Glossip, D., Lu, X., Saito, R. M., Palmer, R. E., Inoue, T., van den Heuvel, S., Sternberg, P. W., & Kornfeld, K. (2004) · Genetics · doi:10.1534/genetics.104.029017 · Cited by 28
“…e1275, n176)atively, and these proteins contain additional domains (Horvitz and Sulston 1980), lin-1(e1777, n303, n304, n383, that are necessary for activation or repression (Laudet n431, n746, n753, n757, n1047, n1054, n1140) (Ferguson and et al. 1999; Mavrothalassitis and Ghysdael 2000).”
BackgroundDhingra, P., Martinez‐Fundichely, A., Berger, A., Huang, F. W., Forbes, A. N., Liu, E. M., Liu, D., Sboner, A., Tamayo, P., Rickman, D. S., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1266-3 · Cited by 30
“ERG is a transcriptional activator, whereas ERF is a transcriptional repressor whose interaction with ETS binding sites can suppress ETS-associated tumorigenesis [87, 88].”
BackgroundBidet, Y., Jagla, T., Ponte, J. P. D., Dastugue, B., & Jagla, K. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00182-5 · Cited by 28
“Two human yan homologues, named tel1 and tel2 (Mavrothalassitis and Ghysdael, 2000; Potter et al., 2000) share similar mesodermal embryonic expression pattern restricted to hematopoietic lineages.”
Gregoricchio, S., Polit, L., Esposito, M., Berthelet, J., Delestré, L., Evanno, E., Diop, M., Gallais, I., Aleth, H., Poplineau, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac613 · Cited by 27
“The SPI1 protein does not contain any transcriptional repression domain (48) but interacts with several cofactors that may mediate its repressive activity.”
BackgroundStams, W. A. G., den Boer, M. L., Beverloo, H. B., Meijerink, J. P. P., van Wering, E. R., Janka-Schaub, G. E., & Pieters, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1829 · Cited by 27
ZNF418, a novel human KRAB/C2H2 zinc finger protein, suppresses MAPK signaling pathway
Li, Y., Yang, D., Bai, Y., Mo, X., Huang, W., Yuan, W., Yin, Z., Deng, Y., Murashko, O. N., Wang, Y., et al. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9674-4 · Cited by 27
“tional repressors such as the ETS-type repressors [35].”
BackgroundBalasubramanian, M., Lord, H., Lévesque, S., Guturu, H., Thuriot, F., Sillon, G., Wenger, A. M., Sureka, D., Lester, T., Johnson, D. S., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104143 · Cited by 27
Sugimoto, H., Okamura, K., Sugimoto, S., Satou, M., Hattori, T., Vance, D. E., & Izumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503578200 · Cited by 27
Biswas, A., Rajesh, Y., Mitra, P., & Mandal, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188389 · Cited by 26
Comparative Analysis of Immune Cells Reveals a Conserved Regulatory Lexicon
Donnard, E. R., Vangala, P., Afik, S., McCauley, S. M., Nowosielska, A., Küçükural, A., Tabak, B., Zhu, X., Diehl, W. E., McDonel, P. E., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.01.002 · Cited by 28
“Enrichment of ETV and STAT motifs on regions that lose availability is consistent with their reported repressive function (Icardi et al., 2012; Mavrothalassitis and Ghysdael, 2000) (Figure 6C).”
BackgroundGuerry, F., Marti, C.-O., Zhang, Y., Moroni, P. S., Jaquiéry, E., & Müller, F. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.03.026 · Cited by 28
“Transcriptional repression by ETS family proteins through chromatin structure and DNA accessibility has previously been shown to occur in a considerable number of different processes and organisms (Hsu and Schulz, 2000; Li et al., 2000; Mavrothalassitis and Ghysdael, 2000).”
BackgroundDecoding the function and regulation of the mammalian 12-h clock
Zhu, B. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa021 · Cited by 26
“For the ETS family, ETV6 is the most likely candidate as it has been found to strongly repress EBS-driven transcription (Mavrothalassitis and Ghysdael, 2000).”
BackgroundLoss of Protein Kinase C δ Gene Expression in Human Squamous Cell Carcinomas
Yadav, V., Yanez, N. C., Fenton, S. E., & Denning, M. F. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090816 · Cited by 24
Stuparević, I., Novačić, A., Rahmouni, A. R., Fernandez, A., Lamb, N. J. C., & Primig, M. (2021) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12693 · Cited by 26
“…Treisman (1994) ERF Erythroblast transformation specific (ETS) domaincontaining repressor implicated in cell proliferation for review, see Mavrothalassitis & Ghysdael (2000) ERG ETS domain TF associated with a variety of cancers, including prostate cancer, Ewing’s sarcoma and acute…”
BackgroundZhang, G., Tian, X., Li, Y., Wang, Z.-Q., Li, X., & Zhu, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.029 · Cited by 22
Identification of transcripts modulated by ETV6 expression
Boily, G., Larose, J., Langlois, S., & Sinnett, D. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06377.x · Cited by 27
“…Compilation ª 2006 Blackwell Publishing Ltd, British Journal of Haematology, 136, 48–62 Note that other ETS members, for example Net and Elk-1, have the capacity to either activate or repress transcription depending on the signalling context (Mavrothalassitis & Ghysdael, 2000; Yang et al, 2001).”
BackgroundCross-cohort analysis of expression and splicing quantitative trait loci in TOPMed
Orchard, P., Blackwell, T. W., Kachuri, L., Castaldi, P. J., Cho, M. H., Christenson, S. A., Durda, P., Gabriel, S., Hersh, C. P., Huntsman, S., et al. (2026) · Science · doi:10.1126/science.adx2989 · Cited by 24
Popichenko, D., Hugosson, F., Sjögren, C., Dogru, M., Yamazaki, Y., Wolfstetter, G., Schönherr, C., Fallah, M., Hallberg, B., Nguyen, H., et al. (2013) · Development · doi:10.1242/dev.094466 · Cited by 21
“…(ERK) signalling cascade activity and is subsequently exported from the nucleus to the cytoplasm, where it is finally degraded (Hsu and Schulz, 2000; Lai and Rubin, 1992; Mavrothalassitis and Ghysdael, 2000; Rebay and Rubin, 1995; Rogge et al., 1995; Roukens et al., 2008; Tootle et al., 2003).”
BackgroundAncestral state reconstruction by comparative analysis of a GRN kernel operating in echinoderms
Erkenbrack, E. M., Ako-Asare, K., Miller, E., Tekelenburg, S., Thompson, J. R., & Romano, L. (2016) · Development Genes and Evolution · doi:10.1007/s00427-015-0527-y · Cited by 18
Carll, T. C., Patel, A. A., Derman, B. A., Hyjek, E. M., Lager, A. M., Wanjari, P., Segal, J. P., Odenike, O. M., Fidai, S. S., & Arber, D. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001282 · Cited by 18
“ETV6 was initially cloned as a fusion partner gene of PDGFRB in a t(5;12)(q33;p13) translocation, and it is a member of the erythroblast transformation–specific (ETS) family of transcription regulators,(10) one of the largest families of signal-dependent transcription regulators that mediates cell proliferation, diffe…”
BackgroundStasevich, I., Inglott, S., Austin, N., Chatters, S. J., Chalker, J., Addy, D., Dryden, C., Ancliff, P., Ford, A. M., Williams, O., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13543 · Cited by 18
Panagoulias, I., Georgakopoulos, T., Aggeletopoulou, I., Agelopoulos, M., Thanos, D., & Mouzaki, Α. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.762179 · Cited by 18
Inhibitors of Raf kinase and MEK signaling
Ramnath, N., & Adjei, A. A. (2007) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2007.10.001 · Cited by 18
A novel zinc-finger protein ZNF436 suppresses transcriptional activities of AP-1 and SRE
Li, Y., Du, X., Li, F., Deng, Y., Yang, Z., Wang, Y., Pen, Z., Wang, Z., Yuan, W., Zhu, C., et al. (2006) · Molecular Biology Reports · doi:10.1007/s11033-006-9019-5 · Cited by 17
“repressors [25].”
Lopez, R. G., Carron, C., & Ghysdael, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306435200 · Cited by 21
Self-citationEguchi‐Ishimae, M., Eguchi, M., Maki, K., Porcher, C., Shimizu, R., Yamamoto, M. P., & Mitani, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01097.x · Cited by 19
Usmanova, N. M., Tomilin, N., Zhivotovsky, B., & Kropotov, A. (2010) · Biochimie · doi:10.1016/j.biochi.2010.10.002 · Cited by 16
Honda, S., Kobayashi, T., Kajino, K., Urakami, S., Igawa, M., & Hino, O. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10123 · Cited by 15
“These results suggest that Elf-1 may be a negative regulator of Tsc2/Nth1 genes expression and may compete against positive regulators for the binding to EBSs [24].”
BackgroundMolina, M. D., Quirin, M., Haillot, E., de Crozé, N., Range, R., Rouel, M., Jimenez, F., Amrouche, R., Chessel, A., & Lepage, T. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007621 · Cited by 16
Single-cell analysis of cell fate bifurcation in the chordate Ciona
Winkley, K., Reeves, W., & Veeman, M. T. (2021) · BMC Biology · doi:10.1186/s12915-021-01122-0 · Cited by 16
“29 repressive functions have also been described [80].”
BackgroundGrånäs, C., Lundholt, B. K., Loechel, F., Pedersen, H.-C., Bjørn, S. P., Linde, V., Krog-Jensen, C., Nielsen, E.-M. D., Præstegaard, M., & Nielsen, S. J. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106287136 · Cited by 16
“Among the Ets family, nuclear ERF1 is unique because ERKdependent phosphorylation of ERF1 controls the activity of ERF1 by modulating its subcellular localization rather than by controlling its inherent transcriptional activity.(13,14) Upon mitogenic stimulation, ERF1 is immediately phosphorylated by ERK and exported…”
BackgroundSreelakshmi, B. J., Karthika, C. L., Ahalya, S., Kalpana, S., Kartha, C. S., & Sumi, S. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151420 · Cited by 13
Ogawa, H., Murayama, A., Nagata, S., & Fukunaga, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207615200 · Cited by 13
Lan, D., Tang, C., Li, M., & Yue, H. (2010) · Avian Pathology · doi:10.1080/03079451003716383 · Cited by 12
“In addition, it can form a co-repressor with SMRT, mSin3A or N-CoR to repress the expression of cell genes (Chakrabarti & Nucifora, 1999; Mavrothalassitis & Ghysdael, 2000).”
BackgroundERK signaling dissolves ERF repression condensates in living embryos
Weaver, C. J., Patel, A. L., Shvartsman, S. Y., Levine, M., & Treen, N. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119187119 · Cited by 11
Genome wide mapping of ETV6 binding sites in pre-B leukemic cells
Neveu, B., Caron, M., Lagacé, K., Richer, C., & Sinnett, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-33947-1 · Cited by 13
Segura‐Bautista, D., Olivares, A., Casas-González, P., Bonilla, E., Salazar, Z., & P�rez‐Solis, M. (2020) · Oncology Reports · doi:10.3892/or.2020.7540 · Cited by 10
Genetic distinction between functional tissue-resident and conventional natural killer cells
Hu, L., Han, M., Deng, Y., Gong, J., Hou, Z., Zeng, Y., Zhang, Y., He, J., & Zhong, C. (2023) · iScience · doi:10.1016/j.isci.2023.107187 · Cited by 9
Kim, J., Won, H., & Kang, S. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24481 · Cited by 9
RAGE against the stress: Mitochondrial suppression in hypometabolic hearts
Al-attar, R., & Storey, K. B. (2020) · Gene · doi:10.1016/j.gene.2020.145039 · Cited by 8
Metadata
- Authors
- Mavrothalassitis, G., & Ghysdael, J.
- Affiliations
- University of Crete (GR)
- Centre National de la Recherche Scientifique (FR)
- Venue
- Oncogene
- Published
- 2000-12-18
- Volume
- 19
- Issue
- 55
- Pages
- 6524-6532
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007244502
- Cited by
- 153
- References
- 102
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 14 · 2020: 8 · 2019: 2 · 2018: 6 · 2017: 8 · 2016: 6 · 2015: 2 · 2014: 3 · 2013: 8 · 2012: 5
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- ETS transcription factors, transcriptional repression, Yan, ERF, .NET, TEL, repression domain, MAPK signaling, ERK, cell proliferation, cell differentiation, carcinogenesis
- MeSH terms
- ETS Translocation Variant 6 Protein, Animals, Bone Neoplasms, DNA-Binding Proteins, Eye Proteins, Gene Expression Regulation, Multigene Family, Hematopoiesis, Humans, Leukemia, Models, Genetic, Neoplasm Proteins, Nerve Tissue Proteins, Proto-Oncogene Proteins, Repressor Proteins, Sarcoma, Ewing, Transcription Factors, Transcription, Genetic, Transfection, Translocation, Genetic, Signal Transduction, Oncogene Proteins, Trans-Activators, 3T3 Cells, Alternative Splicing, Protein Structure, Tertiary, MAP Kinase Signaling System, Drosophila Proteins, Proto-Oncogene Proteins c-ets, Proto-Oncogene Protein c-ets-2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.